JETRO Announcements"JETRO Global Open Innovation (GOI) Symposium" archive is now available

Mar 03, 2023

On October 13, 2022, JETRO held the JETRO Global Open Innovation (GOI) Symposium in BioJapan2022 at Pacifico Yokohama.

This symposium was organized in collaboration with the Ministry of Economy, Trade and Industry, the Pharmaceutical Research and Manufacturers of America (PhRMA), the American Medical Devices and Diagnostics Manufacturers' Association (AMDD), and the European Federation of Pharmaceutical Industries and Associations, Japan (EFPIA Japan). The symposium introduced the aims and current status of international collaboration in Japan’s industry associations and academia, respectively. In addition, it featured reverse pitches by foreign-affiliated companies in Japan seeking to collaborate with Japanese academia and companies, as well as pitches by foreign companies with innovative products and services, both in the healthcare field (pharmaceuticals, medical devices, digital health, etc.) (Note).

Note: Pitches were made in the form of video playback.

Agenda in the Archive
Opening remarks by the organizer Japan External Trade Organization (JETRO)
By Ms. Mio Kawada, Executive Vice President
Speeches by guests of honor
  1. (1) Japan-Based Executive Committee(JBEC), Pharmaceutical Research and Manufacturers of America (PhRMA)
    By Mr. James C. Feliciano, Chairperson
    (President of AbbVie GK)
  2. (2) American Medical Devices and Diagnostics Manufacturers' Association (AMDD)
    By Mr. Kazuya Ogawa, Chairperson
    (Chairman and President, Board Members of Zimmer Biomet G.K.)
  3. (3) European Federation of Pharmaceutical Industries and Associations, Japan (EFPIA Japan)
    By Mr. Takahiko Iwaya, Chair
    (President of Sanofi K.K.)
Keynote speeches
  1. (1)“International Collaborations with Greater Tokyo Biocommunity (GTB)”
    Greater Tokyo Biocommunity (GTB) Council
    By Mr. Osamu Nagayama, Chairman
    (President of Japan Bioindustry Association (JBA) /Special Advisor Honorary Chairman of Chugai Pharmaceutical Co., Ltd.)
  2. (2)“Global Development of Cancer Drugs and Medical Devices from Japan”
    National Cancer Center Hospital East
    By Dr. Atsushi Ohtsu, Director
  3. (3)“National Cerebral and Cardiovascular Center’s Initiatives Aimed at Creating Open Innovation and Its Global Expansion”
    National Cerebral and Cardiovascular Center
    By Dr. Kinya Otsu, Chairman
  • Reverse pitches by foreign-affiliated companies in Japan (6 companies)
  • Pitches by foreign companies (12 companies)
Closing Remarks Investment Facilitation Division, Trade and Economic Cooperation Bureau
Ministry of Economy, Trade and Industry (METI)
By Ms. Fujiko Amano, Director for Investment Facilitation

Contact Us

Investing in Japan

We will do our very best to support your business expansion into and within Japan. Please feel free to contact us via the form below for any inquiries.

Inquiry Form

JETRO Worldwide

Our network covers over 50 countries worldwide. You can contact us at one of our local offices near you for consultation.

Overseas Offices